NCT06428422View on ClinicalTrials.gov

The Impact of Probiotic on Survival and Treatment Response in Metastatic Non-small Cell Lung Cancer Patients

NARecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

August 12, 2024

Primary Completion Date

October 31, 2025

Study Completion Date

December 20, 2026

Conditions
Metastatic Non-small Cell Lung Cancer
Interventions
DIETARY_SUPPLEMENT

Bifidobacterium animalis subsp. lactis Bl-04

4 x 10\^9 cfu/g/day Bifidobacterium animalis subsp. lactis Bl-04 for 12 weeks

OTHER

Plasebo

1 g/day maltodextrin for 12 weeks

Trial Locations (1)

42090

RECRUITING

Necmettin Erbakan University, Konya

All Listed Sponsors
collaborator

Health Institutes of Turkey

OTHER_GOV

lead

Necmettin Erbakan University

OTHER